Bio-Rad Laboratories
(BIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 589,869 | N/A | 39,500 | 17,400 | 12,400 |
| Depreciation Amortization | N/A | N/A | 106,000 | 70,700 | 33,700 |
| Accounts receivable | N/A | 2,093,948 | -22,400 | -1,800 | 6,800 |
| Accounts payable and accrued liabilities | -543,700 | -1,916,119 | -14,500 | -24,200 | -61,200 |
| Other Working Capital | -547,323 | 103,469 | -122,600 | -84,000 | -98,100 |
| Other Operating Activity | 541,500 | -177,161 | 48,800 | 28,200 | 50,197 |
| Operating Cash Flow | $40,346 | $104,137 | $34,800 | $6,300 | $-56,203 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,434 | 16,114 | 1,377 | -5,252 | 2,466 |
| PPE Investments | -27,166 | -111,246 | -85,202 | -64,930 | -39,317 |
| Net Acquisitions | 6,919 | -76,645 | -74,874 | -73,573 | -73,541 |
| Purchase Sale Intangibles | -3 | -3,795 | -3,790 | -3,920 | N/A |
| Other Investing Activity | -3 | -3,795 | -3,790 | -3,920 | 0 |
| Investing Cash Flow | $-18,816 | $-175,572 | $-162,489 | $-147,675 | $-110,392 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | -316 | N/A | N/A | N/A |
| Debt Repayment | -87 | N/A | -220 | -149 | -76 |
| Common Stock Issued | 3,872 | 14,604 | 3,622 | 3,778 | 3,890 |
| Common Stock Repurchased | N/A | -2,920 | -2,920 | -883 | N/A |
| Other Financing Activity | -1,270 | -11,027 | -3,717 | -3,141 | -3,141 |
| Financing Cash Flow | $2,515 | $341 | $-3,235 | $-395 | $673 |
| Exchange Rate Effect | -1,383 | -1,094 | 3,823 | 7,190 | 1,338 |
| Beginning Cash Position | 384,983 | 457,171 | 457,171 | 457,171 | 457,171 |
| End Cash Position | 407,645 | 384,983 | 330,042 | 322,588 | 292,587 |
| Net Cash Flow | $22,662 | $-72,188 | $-127,129 | $-134,583 | $-164,584 |
| Free Cash Flow | |||||
| Operating Cash Flow | 40,346 | 104,137 | 34,800 | 6,300 | -56,203 |
| Capital Expenditure | -27,184 | -111,332 | -85,264 | -64,951 | -39,332 |
| Free Cash Flow | 13,162 | -7,195 | -50,464 | -58,651 | -95,535 |